Literature DB >> 9870359

Different O-glycosylation of respiratory mucin glycopeptides from a patient with cystic fibrosis.

K A Thomsson1, I Carlstedt, N G Karlsson, H Karlsson, G C Hansson.   

Abstract

The O-linked oligosaccharides from three fractions of highly glycosylated mucin glycopeptides obtained from sputum of a patient with cystic fibrosis were characterized and compared regarding size, composition, sequence and when possible linkage positions. Neutral and sialic acid-containing glycans were permethylated and analyzed by high-temperature GC-MS and MALDI-MS, showing more than 60 different oligosaccharides with a size of up to 15 monosaccharide units. Some of the observed oligosaccharides are novel for respiratory secretions, one being a trifucosylated heptasaccharide with the proposed structure: Fuc-Gal-4(Fuc-3)GlcNAc-(Fuc-)Gal-3GalNAcol. The glycosylation of two of the glycopeptide fractions was similar with regard to the neutral and sialylated oligosaccharides despite their different origins from the sol or gel phase. Analysis of the sulfated oligosaccharides by FAB-MS/MS indicated that the gel fraction contained C-6 linked sulfate groups while the two sol fractions also contained C-3 linked sulfate. The results suggest the presence of different glycosylated mucin domains, probably originating from different mucin glycoforms and/or apoproteins in the airway of cystic fibrosis patients.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9870359     DOI: 10.1023/a:1006920219069

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  26 in total

1.  Main structures of the Forssman glycolipid hapten and a Leb-like glycolipid of dog small intestine, as revealed by mass spectrometry. Difference in ceramide structure related to tissue localization.

Authors:  E L Smith; J M Mckibbin; K A Karlsson; I Pascher; B E Samuelsson
Journal:  Biochim Biophys Acta       Date:  1975-05-22

2.  Respiratory mucins: identification of core proteins and glycoforms.

Authors:  D J Thornton; I Carlstedt; M Howard; P L Devine; M R Price; J K Sheehan
Journal:  Biochem J       Date:  1996-06-15       Impact factor: 3.857

Review 3.  Cystic fibrosis.

Authors:  P B Davis; M Drumm; M W Konstan
Journal:  Am J Respir Crit Care Med       Date:  1996-11       Impact factor: 21.405

4.  Isolation and structural characterization of low-molecular-mass monosialyl oligosaccharides derived from respiratory-mucus glycoproteins of a patient suffering from bronchiectasis.

Authors:  H Van Halbeek; J Breg; J F Vliegenthart; A Klein; G Lamblin; P Roussel
Journal:  Eur J Biochem       Date:  1988-11-01

5.  Heterogeneity of mucus glycoproteins from cystic fibrotic sputum. Are there different families of mucins?

Authors:  D J Thornton; J K Sheehan; I Carlstedt
Journal:  Biochem J       Date:  1991-06-15       Impact factor: 3.857

6.  Increased sulfation of glycoconjugates by cultured nasal epithelial cells from patients with cystic fibrosis.

Authors:  P W Cheng; T F Boat; K Cranfill; J R Yankaskas; R C Boucher
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

7.  Identification of two glycoforms of the MUC5B mucin in human respiratory mucus. Evidence for a cysteine-rich sequence repeated within the molecule.

Authors:  D J Thornton; M Howard; N Khan; J K Sheehan
Journal:  J Biol Chem       Date:  1997-04-04       Impact factor: 5.157

8.  Sialylation and sulfation of the carbohydrate chains in respiratory mucins from a patient with cystic fibrosis.

Authors:  J M Lo-Guidice; J M Wieruszeski; J Lemoine; A Verbert; P Roussel; G Lamblin
Journal:  J Biol Chem       Date:  1994-07-22       Impact factor: 5.157

9.  Sulfated sialyl-oligosaccharides derived from tracheobronchial mucous glycoproteins of a patient suffering from cystic fibrosis.

Authors:  T P Mawhinney; D C Landrum; D A Gayer; G J Barbero
Journal:  Carbohydr Res       Date:  1992-11-04       Impact factor: 2.104

10.  Strategy for the investigation of O-linked oligosaccharides from mucins based on the separation into neutral, sialic acid- and sulfate-containing species.

Authors:  N G Karlsson; H Karlsson; G C Hansson
Journal:  Glycoconj J       Date:  1995-02       Impact factor: 2.916

View more
  5 in total

Review 1.  Cellular and molecular biology of airway mucins.

Authors:  Erik P Lillehoj; Kosuke Kato; Wenju Lu; Kwang C Kim
Journal:  Int Rev Cell Mol Biol       Date:  2013       Impact factor: 6.813

Review 2.  Human airway mucin glycosylation: a combinatory of carbohydrate determinants which vary in cystic fibrosis.

Authors:  G Lamblin; S Degroote; J M Perini; P Delmotte; A Scharfman; M Davril; J M Lo-Guidice; N Houdret; V Dumur; A Klein; P Rousse
Journal:  Glycoconj J       Date:  2001-09       Impact factor: 2.916

3.  Pseudomonas aeruginosa mucoid strain 8830 binds glycans containing the sialyl-Lewis x epitope.

Authors:  Baoyun Xia; Goverdhan P Sachdev; Richard D Cummings
Journal:  Glycoconj J       Date:  2007-01       Impact factor: 2.916

4.  Acidic pH increases airway surface liquid viscosity in cystic fibrosis.

Authors:  Xiao Xiao Tang; Lynda S Ostedgaard; Mark J Hoegger; Thomas O Moninger; Philip H Karp; James D McMenimen; Biswa Choudhury; Ajit Varki; David A Stoltz; Michael J Welsh
Journal:  J Clin Invest       Date:  2016-01-25       Impact factor: 14.808

5.  Two glycosylation alterations of mouse intestinal mucins due to infection caused by the parasite Nippostrongylus brasiliensis.

Authors:  Jessica M Holmén; Fredrik J Olson; Hasse Karlsson; Gunnar C Hansson
Journal:  Glycoconj J       Date:  2002-01       Impact factor: 2.916

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.